1.Plasma Glucose Regulation and Mortality in Korea: A Pooled Analysis of Three Community-Based Cohort Studies.
Nan Hee KIM ; Dong Jun KIM ; Seok Won PARK ; Jee Young OH ; Joong Yeol PARK ; Chol SHIN ; Hong Kyu LEE ; Yongsoo PARK
Diabetes & Metabolism Journal 2014;38(1):44-50
BACKGROUND: Although diabetes is a well-known risk factor for death, its impact on cancer death is not clearly understood. Furthermore, it remains controversial whether impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT) are associated with increased risk of mortality. We investigated the impact of diabetes or glucose tolerance categories on all cause and cause-specific mortality. METHODS: Mortality analysis was conducted in three population-based cohort studies of 3,801 participants, divided according to fasting plasma glucose (FPG) (normal; stage 1 IFG [5.6< or =FPG<6.1 mmol/L]; stage 2 IFG [6.1< or =FPG<7.0 mmol/L]; diabetes mellitus [DM]-FPG); or 2-hour glucose after 75 g glucose loading (2hPG) (normal; IGT; DM-2hPG), or a combination of FPG and 2hPG criteria. RESULTS: During a median follow-up of 11.0 years, 474 subjects died from all causes. Hazard ratios (HRs) for all cause death were higher in those with diabetes as defined by either FPG or 2hPG criteria than their normal counterparts (HR, 2.2, 95% confidence interval [CI], 1.6 to 2.9 for DM-FPG; HR, 2.0, 95% CI, 1.5 to 2.7 for DM-2hPG). Similarly, diabetes defined by either FPG or 2hPG was associated with cancer death (HR, 2.9, 95% CI, 1.7 to 5.0; and HR, 2.1, 95% CI, 1.2 to 3.9, respectively). Although neither IFG nor IGT conferred higher risk for death, when combining stage 2 IFG and/or IGT, the risk of all cause death was higher than in subjects with normal glucose regulation (HR, 1.3; 95% CI, 1.0 to 1.6). CONCLUSION: Diabetes is associated with higher risk of death from all causes and cancer. In subjects without diabetes, stage 2 IFG and/or IGT confers increased risk for mortality.
Blood Glucose*
;
Cohort Studies*
;
Diabetes Mellitus
;
Fasting
;
Follow-Up Studies
;
Glucose
;
Glucose Intolerance
;
Korea*
;
Mortality*
;
Plasma*
;
Risk Factors
2.Prevalence, Awareness, and Management of Obesity in Korea: Data from the Korea National Health and Nutrition Examination Survey (1998-2011).
Chul Sik KIM ; Seung Hyun KO ; Hyuk Sang KWON ; Nan Hee KIM ; Jae Hyeon KIM ; Soo LIM ; Sung Hee CHOI ; Kee Ho SONG ; Jong Chul WON ; Dae Jung KIM ; Bong Yun CHA
Diabetes & Metabolism Journal 2014;38(1):35-43
BACKGROUND: Obesity is a risk factor for diabetes and several cardiovascular diseases. This study was to investigate the trends in the prevalence, awareness, and management status of obesity among the Korean population for recent 13 years. METHODS: The prevalence, subjective awareness, and management of obesity were investigated in adults aged > or =19 years by using the data from the Korea National Health and Nutrition Examination Surveys (KNHANES) 1998 to 2011. RESULTS: The number of participants was 8,117, 5,826, 5,500, 3,025, 6,756, 7,506, 6,255, and 6,155 in the KNHANES in years 1998, 2001, 2005, 2007, 2008, 2009, 2010, and 2011, respectively. The prevalence of obesity was 26.9%, 29.2%, 32.9%, 32.5%, 32.0%, 32.6%, 32.0%, and 32.0% in 1998, 2001, 2005, 2007, 2008, 2009, 2010, and 2011, respectively, while the overall prevalence of obesity and abdominal obesity increased by 1.19-fold and 1.24-fold respectively in 2011 compared against 2001. In general, a gradual increase in the prevalence of severe obesity has been observed as years go by. Furthermore, trends of improvements in obesity awareness and management rates were visible over the period of surveys. CONCLUSION: Although the management status of obesity has improved during the recent years, more effective strategy to control obesity is needed.
Adult
;
Cardiovascular Diseases
;
Diabetes Mellitus
;
Humans
;
Korea*
;
Nutrition Surveys*
;
Obesity*
;
Obesity, Abdominal
;
Obesity, Morbid
;
Prevalence*
;
Risk Factors
4.Current Status of Diabetic Peripheral Neuropathy in Korea: Report of a Hospital-Based Study of Type 2 Diabetic Patients in Korea by the Diabetic Neuropathy Study Group of the Korean Diabetes Association.
Jong Chul WON ; Sang Soo KIM ; Kyung Soo KO ; Bong Yun CHA
Diabetes & Metabolism Journal 2014;38(1):25-31
Diabetic peripheral neuropathy (DPN) is the most common complication associated with diabetes. DPN can present as a loss of sensation, may lead to neuropathic ulcers, and is a leading cause of amputation. Reported estimates of the prevalence of DPN vary due to differences in study populations and diagnostic criteria. Furthermore, the epidemiology and clinical characteristics of DPN in Korean patients with type 2 diabetes mellitus (T2DM) are not as well understood as those of other complications of diabetes such as retinal and renal disease. Recently, the Diabetic Neuropathy Study Group of the Korean Diabetes Association (KDA) conducted a study investigating the impact of DPN on disease burden and quality of life in patients with T2DM and has published some data that are representative of the nation. This review investigated the prevalence and associated clinical implications of DPN in Korean patients with diabetes based on the KDA study.
Amputation
;
Diabetes Mellitus, Type 2
;
Diabetic Neuropathies*
;
Epidemiology
;
Humans
;
Korea*
;
Peripheral Nervous System Diseases*
;
Prevalence
;
Quality of Life
;
Retinaldehyde
;
Sensation
;
Ulcer
5.The Hijacking of Cellular Signaling and the Diabetes Epidemic: Mechanisms of Environmental Disruption of Insulin Action and Glucose Homeostasis.
Diabetes & Metabolism Journal 2014;38(1):13-24
The burgeoning epidemic of metabolic disease causes significant societal and individual morbidity and threatens the stability of health care systems around the globe. Efforts to understand the factors that contribute to metabolic derangements are critical for reversing these troubling trends. While excess caloric consumption and physical inactivity superimposed on a susceptible genetic background are central drivers of this crisis, these factors alone fail to fully account for the magnitude and rapidity with which metabolic diseases have increased in prevalence worldwide. Recent epidemiological evidence implicates endocrine disrupting chemicals in the pathogenesis of metabolic diseases. These compounds represent a diverse array of chemicals to which humans are exposed via multiple routes in adulthood and during development. Furthermore, a growing ensemble of animal- and cell-based studies provides preclinical evidence supporting the hypothesis that environmental contaminants contribute to the development of metabolic diseases, including diabetes. Herein are reviewed studies linking specific endocrine disruptors to impairments in glucose homeostasis as well as tying these compounds to disturbances in insulin secretion and impairments in insulin signal transduction. While the data remains somewhat incomplete, the current body of evidence supports the hypothesis that our chemically polluted environment may play a contributing role in the current metabolic crisis.
Delivery of Health Care
;
Diabetes Mellitus
;
Endocrine Disruptors
;
Glucose*
;
Homeostasis*
;
Humans
;
Insulin Resistance
;
Insulin*
;
Metabolic Diseases
;
Prevalence
;
Signal Transduction
6.Gestational Diabetes Mellitus in Korean Women: Similarities and Differences from Other Racial/Ethnic Groups.
Diabetes & Metabolism Journal 2014;38(1):1-12
Gestational diabetes mellitus (GDM) reflects defects in insulin secretion in response to the metabolic demands of pregnancy. While GDM is increasingly common worldwide due in large part to the obesity epidemic, its frequency is relatively low in Korean women. In this report, the prevalence and risk factors for GDM, perinatal outcomes, and postpartum course are compared in non-Korean and Korean women. While Koreans and non-Koreans with GDM share pathophysiology and complications, there may be differences in the role of obesity and thus the effectiveness of interventions targeting obesity in GDM women. Further investigations of the effectiveness of weight loss interventions and pharmacotherapy specifically among Korean women are needed. Dietary and other lifestyle data from Korean populations could inform prevention and treatment strategies in other countries which suffer from significantly higher prevalences of GDM.
Diabetes, Gestational*
;
Drug Therapy
;
Epidemiology
;
Female
;
Humans
;
Insulin
;
Life Style
;
Obesity
;
Postpartum Period
;
Pregnancy
;
Prevalence
;
Risk Factors
;
Weight Loss
7.Corrigendum: Author's Name and Affiliation Correction: The Effect of 12 Weeks Aerobic, Resistance, and Combined Exercises on Omentin-1 Levels and Insulin Resistance among Type 2 Diabetic Middle-Aged Women.
Zeinab AMINILARI ; Mohammad FARAROUEI ; Sasan AMANAT ; Ehsan SINAEI ; Aria DIANATINASAB ; Mahmood AMINILARI ; Nima DANESHI ; Mostafa DIANATINASAB
Diabetes & Metabolism Journal 2017;41(5):422-422
One of the authors' names and affiliations was misprinted.
8.Response: Effects of High-Dose α-Lipoic Acid on Heart Rate Variability of Type 2 Diabetes Mellitus Patients with Cardiac Autonomic Neuropathy in Korea (Diabetes Metab J 2017;41:275-83).
Chong Hwa KIM ; Sol Jae LEE ; Bong Yun CHA
Diabetes & Metabolism Journal 2017;41(5):420-421
No abstract available.
Diabetes Mellitus, Type 2*
;
Heart Rate*
;
Heart*
;
Humans
;
Korea*
9.Letter: Effects of High-Dose α-Lipoic Acid on Heart Rate Variability of Type 2 Diabetes Mellitus Patients with Cardiac Autonomic Neuropathy in Korea (Diabetes Metab J 2017;41:275-83).
Diabetes & Metabolism Journal 2017;41(5):417-419
No abstract available.
Diabetes Mellitus, Type 2*
;
Heart Rate*
;
Heart*
;
Humans
;
Korea*
10.Generation of Insulin-Expressing Cells in Mouse Small Intestine by Pdx1, MafA, and BETA2/NeuroD.
So Hyun LEE ; Marie RHEE ; Ji Won KIM ; Kun Ho YOON
Diabetes & Metabolism Journal 2017;41(5):405-416
BACKGROUND: To develop surrogate insulin-producing cells for diabetes therapy, adult stem cells have been identified in various tissues and studied for their conversion into β-cells. Pancreatic progenitor cells are derived from the endodermal epithelium and formed in a manner similar to gut progenitor cells. Here, we generated insulin-producing cells from the intestinal epithelial cells that induced many of the specific pancreatic transcription factors using adenoviral vectors carrying three genes: PMB (pancreatic and duodenal homeobox 1 [Pdx1], V-maf musculoaponeurotic fibrosarcoma oncogene homolog A [MafA], and BETA2/NeuroD). METHODS: By direct injection into the intestine through the cranial mesenteric artery, adenoviruses (Ad) were successfully delivered to the entire intestine. After virus injection, we could confirm that the small intestine of the mouse was appropriately infected with the Ad-Pdx1 and triple Ad-PMB. RESULTS: Four weeks after the injection, insulin mRNA was expressed in the small intestine, and the insulin gene expression was induced in Ad-Pdx1 and Ad-PMB compared to control Ad-green fluorescent protein. In addition, the conversion of intestinal cells into insulin-expressing cells was detected in parts of the crypts and villi located in the small intestine. CONCLUSION: These data indicated that PMB facilitate the differentiation of mouse intestinal cells into insulin-expressing cells. In conclusion, the small intestine is an accessible and abundant source of surrogate insulin-producing cells.
Adenoviridae
;
Adult Stem Cells
;
Animals
;
Endoderm
;
Epithelial Cells
;
Epithelium
;
Fibrosarcoma
;
Gene Expression
;
Genes, Homeobox
;
Insulin
;
Intestine, Small*
;
Intestines
;
Mesenteric Arteries
;
Mice*
;
Oncogenes
;
RNA, Messenger
;
Stem Cells
;
Transcription Factors